Light Mode
$2.65 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.65, $0.34 below the day’s high of $2.99
-2.58 (-49.33%) / 6M
Momentum, market sentiment, and recent alerts
IMDX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -56.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The company was founded in September 2009 and is headquartered in Nashville, TN.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.